AHA Comments to CMS on the International Pricing Index Model for Medicare Part B Drugs

AHA comments on the Centers for Medicare & Medicaid Services’ advance notice of proposed rulemaking on the International Pricing Index model for Medicare Part B drugs.

Related Resources

Letter/Comment
The AHA today submitted comments to the Senate Health, Education, Labor and Pensions Committee on their bipartisan discussion draft legislation, the Lower…
AHA Center for Health Innovation Market Scan
To understand what’s really driving Amazon's moves in pharmacy, it’s important to know the back story of Amazon’s $750 million-plus acquisition of PillPack, an…
Special Bulletin
Member
The Centers for Medicare…
Letter/Comment
Public
AHA applauds the U.S. House of Representatives for considering the Strengthening Health Care and Lowering Prescription Drug Costs Act.
Special Bulletin
Member
The Centers for Medicare…
Letter/Comment
Public
AHA letter to Senator Richard J.